Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA: A Cancer J Clin. 2023;73(1):17–48.
2. National Cancer Institute. Cancer stat facts: female breast cancer 2022 [cited 2023 March 9]. Available from: https://seer.cancer.gov/statfacts/html/breast.html
3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39.
4. ••Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72. Validated correlation between pCR and better long-term outcomes in patients with breast cancer.
5. ••Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147–59. Role of capecitabine in patients with residual disease and TNBC.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy in Breast Cancer;International Journal of Molecular Sciences;2024-07-09